Cargando…

Eltrombopag: a new treatment option for chronic refractory adult immune thrombocytopenia

Detalles Bibliográficos
Autor principal: Park, Rojin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377332/
https://www.ncbi.nlm.nih.gov/pubmed/25830121
http://dx.doi.org/10.5045/br.2015.50.1.1
_version_ 1782363884994166784
author Park, Rojin
author_facet Park, Rojin
author_sort Park, Rojin
collection PubMed
description
format Online
Article
Text
id pubmed-4377332
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
record_format MEDLINE/PubMed
spelling pubmed-43773322015-03-31 Eltrombopag: a new treatment option for chronic refractory adult immune thrombocytopenia Park, Rojin Blood Res Editorial Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2015-03 2015-03-24 /pmc/articles/PMC4377332/ /pubmed/25830121 http://dx.doi.org/10.5045/br.2015.50.1.1 Text en © 2015 Korean Society of Hematology http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Park, Rojin
Eltrombopag: a new treatment option for chronic refractory adult immune thrombocytopenia
title Eltrombopag: a new treatment option for chronic refractory adult immune thrombocytopenia
title_full Eltrombopag: a new treatment option for chronic refractory adult immune thrombocytopenia
title_fullStr Eltrombopag: a new treatment option for chronic refractory adult immune thrombocytopenia
title_full_unstemmed Eltrombopag: a new treatment option for chronic refractory adult immune thrombocytopenia
title_short Eltrombopag: a new treatment option for chronic refractory adult immune thrombocytopenia
title_sort eltrombopag: a new treatment option for chronic refractory adult immune thrombocytopenia
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4377332/
https://www.ncbi.nlm.nih.gov/pubmed/25830121
http://dx.doi.org/10.5045/br.2015.50.1.1
work_keys_str_mv AT parkrojin eltrombopaganewtreatmentoptionforchronicrefractoryadultimmunethrombocytopenia